Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
PLSE on Nasdaq
Robert W. Duggan - trading volume in the past year for Pulse Biosciences, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
47.5M |
$523M |
$11.00 |
Dec 18, 2024 |
Direct |
|
|
| Common Stock |
630K |
$6.93M |
$11.00 |
Dec 18, 2024 |
Affiliated Company 1 |
|
|
| Common Stock |
450K |
$4.95M |
$11.00 |
Dec 18, 2024 |
Affiliated Company 2 |
|
|
| Warrant (right to buy) |
2.59M |
|
|
Jul 3, 2024 |
Direct |
Common Stock |
|
| Warrant (right to buy) |
34.5K |
|
|
Jul 3, 2024 |
Affiliated Company 1 |
Common Stock |
|
| Warrant (right to buy) |
24.7K |
|
|
Jul 3, 2024 |
Affiliated Company 2 |
Common Stock |
|
| Stock Option (right to buy) |
16.2K |
|
|
Jun 6, 2024 |
Direct |
Common Stock |
|
| Warrants (right to buy) |
0 |
|
|
Dec 18, 2024 |
Affiliated Company 1 |
Common Stock |
|
| Warrants (right to buy) |
0 |
|
|
Dec 18, 2024 |
Affiliated Company 2 |
Common Stock |
|
| Warrants (right to buy) |
0 |
|
|
Dec 18, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.